Similar articles

• Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.

  Ben-Ari Z, Dhillon AP, Garwood L, Rolles K, Davidson B, Burroughs AK. Ben-Ari Z, et al. Transplant Proc. 1996 Dec;28(6):3624-8. Transplant Proc. 1996. PMID: 8962399 No abstract available.
• Experience in therapy of chronic liver allograft rejection.

  Charco R, Ruiz C, Allende E, Balsells J, Lazaro JL, Murio E, Bilbao I, Gifre E, Margarit C. Charco R, et al. Transplant Proc. 1995 Aug;27(4):2293-4. Transplant Proc. 1995. PMID: 7652811 No abstract available.
• Immunology of liver transplantation: clinical management aspects.

  Shah V, Friedman AL, Navarro VJ. Shah V, et al. Gastroenterologist. 1997 Jun;5(2):137-47. Gastroenterologist. 1997. PMID: 9193931 Review.
• New strategies for the treatment of chronic rejection.

  Hoerbelt R, Muniappan A, Madsen JC, Allan JS. Hoerbelt R, et al. Curr Opin Investig Drugs. 2004 May;5(5):489-98. Curr Opin Investig Drugs. 2004. PMID: 15202721 Review.
• [The rejection of a hepatic graft].

  Pandrea I, Creţu O, Apetrei C, Creţu I, Fluture V, Mihailovici MS. Pandrea I, et al. Chirurgia (Bucur). 1998 Nov-Dec;93(6):375-86. Chirurgia (Bucur). 1998. PMID: 10422358 Review. Romanian.